Shennon Biotechnologies
Develops a single-cell platform for rapid immunotherapy drug discovery.
Company facts
- Founded
- 2021
- Employees
- 16
- Headquarters
- United States
- Type
- Private
- Funding
- Seed · $13M · 2023
Open positions
Operations Manager
About Us: Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional…
Scientist/Senior Scientist in T-cell Engager (TCE) Development
We are a well-funded biotech company that is redefining biologics discovery and development through our fully integrated platform. We combine ultra-high-throughput microfluidics driven functional screening,…
CMC Lead, Multispecific Antibodies (Director level, consulting)
About Us Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional…
Head of Droplet-based Microfluidics Applications - Associate Director
About Us: Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional…